FDA releases plan for antimicrobial stewardship in veterinary settings for 2024-2028

The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) released, “Supporting Antimicrobial Stewardship in Veterinary Settings, Goals for Fiscal Years 2024-2028.” This five-year plan builds upon the progress of the previous plan for FY 2019-2023.

The five-year plans are intended to provide stakeholders with a transparent roadmap of the actions that correspond to FDA’s three main veterinary stewardship goals:

• Align antimicrobial drug product use with the principles of antimicrobial stewardship
• Foster stewardship of antimicrobials in veterinary settings
• Enhance monitoring of antimicrobial resistance (AMR) and antimicrobial drug use in animals

The new plan kicks off October 1, 2023, and advances many of the key activities initiated during the previous plan (2019-2023).

As FDA develops and implements strategies to address individual actions in the plan, it will solicit public feedback on certain key initiatives. Stakeholders and the public can see what FDA has accomplished thus far and follow progress via FDA-TRACK: Progress on FDA’s Support of Antimicrobial Stewardship in Veterinary Settings.

September 27, 2023/ FDA/ United States.
https://www.fda.gov